IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Tepilta® Versus Oxetacaine, Antacids and Placebo
This study has been terminated.
(The study stopped prematurely due to and administrative reasons, not based on grounds of safety.)
Sponsor:
MEDA Pharma GmbH & Co. KG
Collaborators:
Trium Analysis Online GmbH
ICON plc
Clinipace Worldwide
Information provided by (Responsible Party):
MEDA Pharma GmbH & Co. KG
ClinicalTrials.gov Identifier:
NCT01336530
First received: April 1, 2011
Last updated: May 18, 2017
Last verified: February 2017
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | January 2017 |
| Primary Completion Date: | January 2017 (Final data collection date for primary outcome measure) |